Evidence map›Paper›PMID 42641890›Full record

ArticleThe Journal of biological chemistry2026

The Ca

Samriddhi Arora, Abhishek Tanwar, Gyan Ranjan, Rajender K Motiani

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samriddhi AroraLaboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India.
Abhishek TanwarLaboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India.
Gyan RanjanLaboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India.
Rajender K MotianiLaboratory of Calciomics and Systemic Pathophysiology (LCSP), Regional Centre for Biotechnology (RCB), Faridabad, Delhi-NCR, India. Electronic address: rajender.motiani@rcb.res.in.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Pancreatic Cancer (PC) is one of the most aggressive cancers and is associated with poor prognosis. One of the routinely used chemotherapeutic drugs for the treatment of advanced PC is gemcitabine, which offers survival benefits to patients. However, acquired gemcitabine resistance leads to recurrence and metastasis, and the long-term prognosis remains poor. Although there is substantial clinical evidence of gemcitabine resistance, the cellular and molecular mechanisms that drive this resistance remain largely unappreciated. Here, we reveal that Orai3, a Ca

Indexed as

Ca(2+) signalingchemoresistanceNFATc1Orai3pancreatic cancerSLIT3store operated calcium entry

Identifiers

PMID42641890
PMCPMC13625800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.